Dr. Xiangna Tang is a board-certified Obstetrician/Gynecologist with subspecialty in Maternal Fetal Medicine. She received her medical degree from Xiangya School of Medicine in Changsha, China, an esteemed institution established by the Yale-China Association over a century ago. After completing her residency in Obstetrics and Gynecology at Lincoln Medical Center in the Bronx, Dr. Tang pursued further training of maternal fetal medicine fellowship at Wayne State University/Detroit Medical Center/Perinatology Research Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute of Health.

During her fellowship, Dr. Tang had the privilege of working alongside world-renowned physicians and scholars in the field of ultrasound medicine, honing her expertise in fetal imaging, particularly in the area of congenital cardiac diseases, fetal cardiac dysfunction. This invaluable experience has equipped her with the necessary skills to assist women facing complex and high-risk pregnancies. Dr. Tang is dedicated to providing exceptional care to those who are dealing with severe complications, including rare and life-threatening conditions that require accurate and timely diagnosis in both the mother and fetus.

Beyond her professional pursuits, Dr. Tang leads an active and fulfilling lifestyle. She enjoys engaging in various sports and outdoor activities, such as tennis, paddle boarding, hiking, and swimming.

Professional Education, Training and Certification

Board Certification

  • Board Certified in Maternal Fetal Medicine
  • Board Certified in Obstetrics and Gynecology

Professional Education and Training

  • Fellowship: Wayne State University/Detroit Medical Center/Perinatology Research Branch/NICHD/NIH/DHHS
  • Residency: Lincoln Medical Center, Bronx, New York
  • Medical School: Xiangya School of Medicine, Changsha, China

Summary of Professional Research

Grant: 2018-2021 Randomized clinical trial, VAX-MOM (increasing influenza and Tdap vaccination of pregnant women), subaward number 417599/UR FAO:GR510942.

Publications

Lewis G, Dawkins J, Tang X. Umbilical artery aneurysm without aneuploidy and delivery of a live neonate. Case Rep. Perinat. Med 2022;11: 20210091.

Tang X, Hernandez-Andrade E, Ahn H, Garcia M, Saker H, Korzeniewski S, Tarca A, Yeo L, Hassan S, Romero R. Intermediate Diastolic Velocity as a Parameter of Cardiac Dysfunction in Growth-Restricted Fetuses. Fetal Diagn Ther. 2016; 39: 28-39.

Wang ZY, Sun GW, Faucette A, Unger BL, Hong P, Yao F, Guterman J, Mathiarasu A, Deng J, Tang X, Bluth MH, Armant R, Lum LG, Siddiqu M, Chen K. A HEXIM1-AIRE transcriptional counter-balance in trophoblasts regulates maternal-fetal mucosal immunity in pregnancy. Journal of Immunology and the AAI meeting 2014Oral and Poster

Patwardhan M, Ahn H, Hernandez-Andrade E, Korzeniewski S, Hussein Y, Tang X, Chaiworapongsa T, Hassan SS,  Romero R. Dynamic myometrial changes in the upper and lower uterine segments during the third stage of Labor.  22nd World Congress on Ultrasound in Obstetrics and Gynecology. Copenhagen, Denmark, September 2012.

Cui M, Tang X, Christian VW, Yoon Y, and Tieu K. Perturbations in Mitochondrial Dynamics Induced by Human Mutant PINK1 Can Be Rescued by the Mitochondrial Division Inhibitor mdivi-1. J Biol Chem.  2010; 285: 11740–11752.

Tang X, Guruju M, Rajendran GP, Isler CM,  Martin J, Kumar A. Role of C825T polymorphism of GNbeta3 gene in preeclampsia. Hypertens Pregnancy. 2006 ;25: 93-101

Markovic D, Tang X, Guruju M, Levenstien MA, Hoh J, Kumar A, Ott J, Association of angiotensinogen gene polymorphisms with essential hypertension in African-Americans and Caucasians, Hum Hered, 2005; 60: 89-96

Jain S, Tang X, Narayanan CS, Agarwal Y, Peterson SM, Brown CD, Ott J, Kumar A Angiotensinogen Gene Polymorphism at -217 Affects Basal Promoter Activity and is Associated with Hypertension in African-Americans, , J Biol Chem, 2002 , 277: 36889-96